Acta Crystallogr C Struct Chem
September 2020
The first example of an interpenetrated methyl-modified MOF-5 with the formula ZnO(DMBDC)(DMF), where DMBDC is 2,5-dimethylbenzene-1,4-dicarboxylate and DMF is N,N-dimethylformamide (henceforth denoted as MeMOF-5-int), namely, poly[tris(μ-2,5-dimethylbenzene-1,4-dicarboxylato)bis(N,N-dimethylformamide)-μ-oxido-tetrazinc(II)], [Zn(CHO)O(CHNO)], has been obtained from a solvothermal synthesis of 2,5-dimethylbenzene-1,4-dicarboxylic acid and Zn(NO)·6HO in DMF. A systematic study revealed that the choice of solvent is of critical importance for the synthesis of phase-pure MeMOF-5-int, which was thoroughly characterized by single-crystal and powder X-ray diffraction (PXRD), as well as by gas-adsorption analyses. The Brunauer-Emmett-Teller surface area of MeMOF-5-int (660 m g), determined by N adsorption, is much lower than that of nonpenetrated MeMOF-5 (2420 m g).
View Article and Find Full Text PDFTwo mixed-ligand metal-organic frameworks, [Zn(BDHA)(INA)] (MOF-1: HBDHA = benzene-1,4-dihydroxamic acid; HINA = isonicotinic acid) and [Co(BDHA)(INA)(DMF)] (MOF-2), were solvothermally synthesized and fully characterized by single-crystal X-ray crystallography as well as N, H, and CO gas-sorption measurements. The results constitute the first detailed analysis of the bonding environment around the hydroxamates in such MOFs, which are simultaneously decorated with Lewis-basic sites from the hydroxamate moieties and metal sites predisposed for coordinative unsaturation. MOF-2 shows a desirably selective adsorption of CO relative to N.
View Article and Find Full Text PDFIn persistent AF, the effect of adjunctive ablation in addition to PV isolation (PVI) is controversial. We considered a new modified PVI including complex fractionated atrial electrogram (CFAE) area. In 57 patients with persistent AF undergoing first ablation, CFAE were mapped before ablation and CFAE-guided extensive encircling PVI (CFAE-guided EEPVI) was performed.
View Article and Find Full Text PDFObjectives: The purpose of this study was to evaluate long-term clinical impact of routine follow-up coronary angiography (FUCAG) after percutaneous coronary intervention (PCI) in daily clinical practice in Japan.
Background: The long-term clinical impact of routine FUCAG after PCI in real-world clinical practice has not been evaluated adequately.
Methods: In this prospective, multicenter, open-label, randomized trial, patients who underwent successful PCI were randomly assigned to routine angiographic follow-up (AF) group, in which patients were to receive FUCAG at 8 to 12 months after PCI, or clinical follow-up alone (CF) group.